Secretary General of th BGICCon behalf of the conference board

Prof. Hesham El Ghazaly

Gynecological cancers, with discussion of the prospects in the context of the most recent international trends and initiatives for the treatment.

Breast Gynecological International Cancer Society continues in its strive - through our deep sense of responsibility toward the health care community - to give a good platform for the exchange of experience on cancers & to outline the actual status of the problems relating to the Breast.

Immunooncology this year - due to it’s important role and our past years success-will be a special entity inside the conference that will cover all aspects in

oncology from diagnosis, controversies and future in all cancer specialities; holding a recommendation session

about immuno-oncology in practice.

Faculty of Medicine AinShams Research Institute

International Collaboration has been the theme for the BGICC from its first edition and this year, we will underpin the need for collaboration and cooperation in implanting cancer control strategies,

exchange of experience on cancers &networking with

colleagues from around the world ,collaborating with

international societies and high caliber international experts to

make cancer history and the driving force behind this

collaboration is the shared mission of the

organizations and scientists to advance

progress against cancer.

Conference's Scientific Program is designed to

provide state-of-the-art information on breast cancer research, issues;

offering breakthrough advances and insight in scientific and clinical

research, patient management and practice through an outstanding range

of scientific and educational symposia, special sessions, teaching lectures,

workshops, debates and much more. A comprehensive, stimulating and

highly-educational scientific experience is guaranteed for all

Cancer research professionals will gather in a challenge for future eradication of cancer

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

Prof. Hala ZayedMinister of Health and Population

Prof. Khaled Abdel GhaffarMinister of Higher Education

and Scientific Research Prof. Mahmoud EI-MeteiniPresident of Ain Shams University

Prof. Ashraf OmarActing Dean of Faculty of Medicine Ain Shams University

Under Patronage of

Prof. Hussein KhaledProfessor of Medical Oncology

NCI, Cairo University

Prof. Hatem Abou El-KassemDean of NCI

Cairo University

Prof. Mohamed LotayefSecretary general of the

Supreme Council of Universities

Prof. Hamdy Abdel AzimProfessor of Clinical Oncology

Cairo University

Prof. Yasser Abdel KaderProfessor of Clinical Oncology

Cairo University

Prof. Manal MoawadProfessor of Clinical Oncology

Ain Shams University

Honorary Presidents

Prof. Heba EI-ZawahryProfessor of Medical Oncology

NCI

Prof. Omar Z. YoussefProfessor of Surgical Oncology

NCI

Prof. Rasha KamalProfessor of Radiology

Cairo University

Prof. Manal El MahdyProfessor of PathologyAin Shams University

Prof. Mohammed ShinawiProfessor of Surgical Oncology

Ain Shams University

Prof. Khaled AbdelkarimProfessor of Clinical Oncology

Ain Shams University

Prof. Mohamed Abou El FotouhProfessor of Clinical Oncology

Menoufia University

Prof. Samy AlsirafyProfessor of Clinical Oncology

Cairo University

Prof. Ahmed SekotoryProfessor of Gynaecological Oncology

United Kingdom

Dr. Sahar RadyPharmacist, Cairo University

BGICS Treasurer

Prof. Wafaa OudaProfessor of NursingAin Shams University

Prof. Maged Abou SeadaProfessor of Obstetrics and Gynecology

Ain Shams University

Prof. Emad HamadaHead of Clinical Oncology Department

Cairo University

Prof. Ehab MostafaHead of Clinical Oncology Department

Ain Shams University

Prof. Osman MansourHead of Medical Oncology Department - NCI

Cairo University

Prof. Rabab GaafarProfessor of Medical Oncology-NCI

ESMO National and North Africa Representative

Conference Presidents (alphabetical)

Prof. Hesham EI GhazalyProfessor of clinical oncology, Ain Shams University

Director of Medical Research Center (MASRI)President of BGICS

Secretary General & Chair of Scientific Committee

Dr. Nermeen Mostafa Dr. Ramy Baraka Dr. Mohamed Ramadan Dr. Ahmed Mesbah Dr. Lamia Abdallah Dr. Yehea Abou Gabal

Conference Coordinators

Course Directors

Prof. Banu ArunProfessor of Breast Medical Oncology, Co-director Clinical Cancer Genetics, University of Texas, MD AndersonCancer Center, USA.

Prof. Hope RugoProfessor of Medical oncologyUCSF Medical Center USA

Prof. Edith A. PerezVice President and Head U.S. BioOncology Med Unit Director Mayo Clinic Breast CancerTranslational Genomics ProgramUSA

Prof. Sandra M SwainAssociate Dean for Research DevelopmentProfessor of MedicineGeorgetown University Medical CenterUSA

Prof. Giuseppe CuriglianoClinical DirectorDivision of Early Drug Development for Innovative TherapyCo-Chair Cancer Experimental Therapeutics ProgramDepartment of Oncology and Hemato-OncologyUniversity of Milan European Institute of Oncology

Prof. Martine J. PiccartProfessor of Oncology at the Université Libre de Bruxelles (ULB) Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium

Prof. Armando E. GiulianoLinda and Jim Lippman Chair in Surgical OncologyExecutive Vice Chair, Surgical Oncology in the Department of SurgeryCo-Director, Saul and Joyce Brandman Breast Center -A Project of Women's GuildAssociate Director, Surgical Oncology in the Samuel Oschin Comprehensive Cancer Institute, USA

Prof. Benjamin O. AndersonChair and Director, Breast Health Global Initiative (BHGI)Full Member, Fred Hutchinson Cancer Research CenterProfessor of Surgery and Global Health Medicine, University of WashingtonSeattle, Washington USA

Prof. Philip M.P. PoortmansHead of Department of Radiation OncologyMarie Curie Professor Paris Science & Lettres – Institut CurieECCO PresidentFormer ESTRO President, France

Prof. Mehra GolshanAssociate Professorof SurgeryHarvard Medical School Distinguished Chair,Surgical Oncology, Brigham & Women's HospitalDirector, Breast Surgical Services DFBWCC, Brigham And Women's Hospital, USA

Prof. Matti AaproExecutive Director, International Society ofGeriatric Oncology (SIOG) and President, Multinational Association of Supportive Care in Cancer (MASCC)Switzerland

Prof. Wu JiongVice President Chinese Anticancer AssociationSpecialty Branch of Breast Cancer surgeryChina

Prof. Aleix PratHead of Medical Oncology Department Hospital Clinic de Barcelona.Spain

Prof. Joseph GligorovProfessor of Medical OncologyTenon Hospital,President of AROMEFrance

Prof. Valentina GuarneriProfessor of medical oncologyUniversity of Modena and Reggio Emilia Department of Oncology and Hematology Modena, Italy

Prof. Maia DzhugashviliProfessor of Radiation OncologyMadrid Oncology Institute,Spain

Prof. Carlos CentenoProfessor of Palliative Medicine, Faculty of Medicine, University of NavarraDirector of the Palliative MedicineUnit of the University of Navarra ClinicPamplona, Spain

Prof. Fedro PeccatoriDirector of the Fertility and Procreation Unit within the Division of Gynecologic Oncology in the Department of Gynecology at the European Institute of Oncology, Milan Italy., Italy

Prof. Charles M. BalchPresident, Cancer Expert Now InternationalProfessor of SurgeryDepartment of Surgical OncologyUT MD Anderson Cancer Center,Houston Texas, USA

Prof. Philippe MoriceESGO President - Elect Assistant Professor, Department of Gynecologic Surgery. Institut GustaveRoussy, France

Prof. Pascal PujolHead of Cancer Genetics Department,CHU MontpellierFrance

Prof. Marc SpielmannProfessor of medical oncologyBreast Cancer, Institut Gustave-Roussy,France

Prof. Asmus HammerichDirector of NCD, WHO-EMROGermany

Prof. Sanaa ElsukhunProfessor of medical oncologyUniv of jordan,Jordan

Prof. Murat GultekinGynaecological Oncologist Key Opinion Leader, Government Official & Board Member ofLeading Cancer OrganizationsTurkey

Prof. Fredrique PenaulltllorcaProfessor of pathologyDepartment of pathology, center jean-perrinClermont-FerrandFrance

Prof. Pierre F. ConteProfessor of medical oncologyDirector of the school of medical oncologyDepartment of oncology and SurgicalSciences University of padova, Italy

Prof. Roberto OrecchiaPresident of IEOProfessor of radiation oncologyUniversity of Milan Italy

Prof. Neal A.ReadyProfessor of Hematology - OncologyDuke Cancer InstituteUSA

Prof. Ahmed SekotoryMD FRCOG FACOGConsultant Gynaecological OncologistHon professor Alexandria and Zagazig UniversitiesPast Director of Gynaeoncology & Robotic SurgeryThe Christie NHS FTManchester UKGlobal Health Academy, UK

Prof. Omalkhair AbulkhairConsultant medical oncologistKSA

Prof. Marwan GhosnDirector of the cancer center and the headOf hematology & oncology divisionClemenceau medical center affiliatedWith johns Hopkins International in BeirutLebanon

Prof. Adda BoundejarHead of medical oncology departmentAlgeria

Prof. Sami KhatibSecretary General of AMAAC (ArabMedical Association Against Cancer),Jordan

Prof. Raj NaikPast President of BGCS; Chair ofInternational Subgroup Consultant & Headof Northern Gynaecological Oncology CentreGates Head; NottinghamUK

!

Prof. Ebtesam Ahmed Clinical Professor for the Department of Clinical Health ProfessionsSt. John's University New York,USA

Prof. Ahmed SaadeldinConsultant medical oncologistArmed forces Hospital RiyadhKSA

Prof. Nagi SaghirProfessor and the director of theBreast cancer of Excellence,Naef k.Baslle cancer institute atThe American university of BeirutMedical center Lebanon

Dr. Narjiss BerradaMedical Oncology , center of excellence on Breast cancer and gynecologic malgnancies. National Institute of Oncology MoroccoBGICS International Representative

Prof. Tatiana Semiglazova Head of Department, Leading Researcher at the Department of Innovative Methods of Therapeutic Oncology and Rehabilitation,Federal State Budget Institution"National Medical Research Center of Oncology na N.N. Petrov" Ministry of Healthcare of Russian FederationRussia

Prof. Ruslan Malikovich Paltuev CEO of RAOM(Russian Association of OncologyMammalogy)Russia

Prof. Rania BakarProfessor of PathologyCEDARS New MexicoUSA

Prof. Ibrahim ShenbarConsultant surgical oncologistChairman of medical AffairsSaudi cancer FoundationKSA

Prof. Slama Slimworld Health Organization RegionalOffice for the Eastern Mediterranean(EMRO)

Prof. Eduardo GarraldaGeneral Manager of the ATLANTES PalliativeCare Global ObservatoryInstitute for Culture and Society (ICS),University of NavarraPamplona, Spain

Prof. Bahadir GulluogluProfessor of Surgical oncologyMarmara university School of MedicineDepartment of surgeryTurkey

Prof. Rouba AliDirector of Gyne oncology tissue programharber university hospitalUSA

Prof. Denis QuerleuChair, President, Director of ESGO, Professor of Oncology, Obstetrics And Gynecology, Consultant | Bordeaux, Nouvelle-Aquitaine

Prof. Maimuna Mendy Group HeadLaboratory Services and Bio BankWHOFrance

Prof. Jessica Leung Professor of Diagnostic RadiologySection Chief of Breast Imaging,MD Anderson Cancer Center,Tx,USA

Prof. Sunati Sahoo pathologist in Dallas, Texas and is affiliated with UT Southwestern Medical CenterUSA

Prof. Nelly SalemAssistant Professor of Radiology at Stanford University in Palo Alto, California.USA

Prof. Haykushi GeokchyanHead of Oncology Department Erbouni Medical Center

Prof Ahmed Ashour Consultant Gynaecological OncologyDirector of the Ovarian Cancer Cell LaboratoryMRC Weatherall Institute of Molecular MedicineUniversity of Oxford-UK.

Prof . Nafisa WilkinsonConsultant Gynaecological Pathologist, Lead Gynae Pathologist, University College London Hospitals NHS Foundation TrustLeeds, West Yorkshire, UK

Prof. Ramona WoitekProfessor of radiodiagnosis , Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge , UK

Prof. Anupma NayakAssistant Professor of Pathology andLaboratory Medicine at the Hospital of the University of PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine, USA

Prof. Mohamed Elshaikh Senior Staff PhysicianHenry Ford HospitalProfessor of Radiation Oncology.Wayne State UniversityUSA

Prof. Elodie Caboux Assistant-Biobank Process Management, International Agency of Researchon Cancer (IARC), France

Prof. Alena Savanevich, MD, PhD Associate Professor of Oncology, Obstetrics and Gynecology Departments of Grodno StateMedical University, Belarus

Prof. Nadeem R. Abu-RustumChief of the Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center. USA

Prof. Thomas Ind, PhD FRCOGConsultant Gynaecological Oncology SurgeonThe Royal Marsden Hospital; LondonUnited Kingdom

Prof. Ning Liao M.D, Ph.DChair and Director, Department of BreastCancer, Guangdong Cancer Center, GuangdongGeneral Hospital, and Guangdong Academy of Medical Sciences China

Prof. Gilda CardenosaM.D., Director of Breast Imaging at VCU Health,Massey , Cancer Center

Prof Sean Kehoe BGCS FIGO Cancer Committee Member & NCRAS ChairLawson Tait Professor of Gynaecological CancerUniversity of BirminghamChair of Gynaecological Cancer GroupNational Cancer Intelligence NetworkPublic Health England, United Kingdom

Prof. Meteb FoheidiBreast medical oncologistAssociate professorKind Abdul-Aziz medical cityKSA

Dr. Hussein Awad Elkarim Consultant Clinical OncologistGeneral Director of Khartoum Oncology Specialized Center (KOSC)General Secretary of Khartoum Integrated OncologyWorld Congress, Sudan

BGICS International Representative

MAIN TOPICS of The Main Hall

• Molecular biology of Breast oncology - Traditional Pathology and molecular subtypes- New prognostic and predicative biomarkers in breast cancer - Implementation of genetic testing in breast cancer patients

• Management of Triple Negative Breast Cancer patients (TNBC )- Moving into the future of TNBC personalized medicine - Management of BRCA mutation Carrier Patients - Emerging Role of Immunotherapy in TNBC

• Management of Luminal Breast Cancer patients - Neoadjuvant Setting - Challenges and advances - Adjuvant Setting - Escalation and De-escalation in Early Luminal breast cancer therapy

Metastatic Setting - Mechanisms of resistance to CDK4/6inhibitors and new therapeutic approaches- Targeting the cell cycle - Beyond CDK4/6 inhibi-tion - Novel targets in Luminal Breast cancer : New pathways with potential implications in treatment of breast cancer

• Management of Her2 + Breast Cancer patients- Heterogeneity of HER2+ breast cancer- Neoadjuvant treatment : Tailor treatment by

response - New agents for HER2+ treatment- Her2 + Breast Cancer in Special Populations :Clinical dilemmas and scientific challenges- Financial cost and burden in breast cancer care

• Multidisciplinary Approach to Optimizing Local Regional Therapy in Breast Cancer- Surgical Updates- Radiotherapy Updates

• Breast Cancer in Survivors .

• Clinical Practical Recommendations in Multidisci-plinary Management of Triple Negative Breast Cancer (Voting Session )

• Clinical Practical Recommendation in Screening & Prevention of Breast and Cervix cancer (Voting Session )- Breast Cancer Epidemiology- Breast Cancer Screening:CBE versus Mammography - Breast Cancer Screening in High Risk Patients- Non Pharmco Prevention in Breast Cancer- Pharmco Prevention in Breast Cancer- Cervix Cancer Screening - HPV & Cervix Cancer- Cervix Cancer Vaccine and Prevention BGICS-WHO-UICC -ESGO clinical practices Voting Recommendations

IMMUNO-ONCOLOGYCOURSE

Prof. Neal A.ReadyProfessor of MedicineDuke Cancer InstituteUSA

Prof. Mohsen Mokhtar Prof. Hesham Tawfik Prof. Yousry RostomProf. Hesham Elghazaly

Prof. Edith A. PerezVice President and Head U.S. BioOncology Med Unit Director Mayo Clinic Breast CancerTranslational Genomics ProgramUSA

Prof. Hope RugoProfessor of Medical oncologyUCSF Medical Center USA

Prof. Frederique PENAULT-LLORCAProfessor of PathologyDepartment of pathology, center Jean-Perrin Clermont-FerrandPresident of the unicancer immunooncology group, France

Course Directors and International Experts

• Basic Mechanism of Immunotherapy• Update on the recent developments of checkpoint inhibitors• Immune checkpoints: Do we really know how they work?• How to combine with I-O drugs• Combinations with other modalities• How IO Changed the oncology treatment landscape • Biomarker assessment for other I-O therapy (non-PD1)• Cancer neo-antigens • Management of immune related adverse events

: • Immuno-oncology Course (State of Art ) Topics

Prof. Martine J. PiccartProfessor of Oncology at the Université Libre de Bruxelles (ULB) Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium

Prof. Giuseppe CuriglianoClinical DirectorDivision of Early Drug Development for Innovative TherapyCo-Chair Cancer Experimental Therapeutics ProgramDepartment of Oncology and Hemato-OncologyUniversity of Milan European Institute of Oncology

GYNE-ONGOLOGYCOURSE

Honorary Director

Prof. Maged Abuseeda

Co-ordinator

Prof Mohamed Laban

Director

International Experts

Gyneacological Oncology Themes

Pre-Conference Workshop in Collaboration with ESGO

Topics

Cervical Cancer Screening- This course will focus on the early detection of pre-invasive cervical lesions.- The workshop will suit beginners and those who want to update their knowledge and experience in cervical cancer screening. Whilst discussing the most up to date management modalities, the workshop will also present the most practical strategies for screening of cervical cancer in Egypt. Amongst the topics to be presented:1- Patho-physiology of cervical intraepithelial neoplasia2- Principles and strategies of screening for cervical Cancer3- The role of HPV in the development and management of precancerous cervical lesions4- Colposcopic evaluation of the cervix: technique and interpretation5- Visual inspection with acetic acid (VIA) and its role in cervical cancer screening6- Management of cervical intraepithelial neoplasia

Recent updates in the management options of the most common gynaecological malignancies:Ovarian CancerEndometrial CancerCervical CancerGynaecological cancers in the young patients and fertility preservationThe role of minimal access surgery in gynaecological cancers Controversies in the management of endometrial cancers “meet the expert session” Current situation and future direction of gynaecological cancer services in Egypt

Prof. Mohamed Elshaikh Senior Staff PhysicianHenry Ford HospitalProfessor of Radiation Oncology.Wayne State UniversityUSA

Prof. Murat GultekinGynaecological Oncologist Key Opinion Leader, Government Official & Board Member ofLeading Cancer OrganizationsTurkey

Prof. Denis QuerleuChair, President, Director of ESGO, Professor of Oncology, Obstetrics And Gynecology, Consultant | Bordeaux, Nouvelle-Aquitaine

Prof. Thomas Ind, PhD FRCOGConsultant Gynaecological Oncology SurgeonThe Royal Marsden Hospital; LondonUnited Kingdom

Prof. Fedro PeccatoriUniversity of Modena and Reggio Emilia Department of Oncology and Hematology ModenaItaly

Prof. Nadeem R. Abu-RustumChief of the Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center. USA

Prof. Philippe MoriceESGO President - Elect Assistant Professor, Department of Gynecologic Surgery. Institut GustaveRoussy, France

Prof Sean Kehoe BGCS FIGO Cancer Committee Member & NCRAS ChairLawson Tait Professor of Gynaecological CancerUniversity of BirminghamChair of Gynaecological Cancer GroupNational Cancer Intelligence NetworkPublic Health England, United Kingdom

Prof. Raj NaikPast President of BGCS; Chair ofInternational Subgroup Consultant & Headof Northern Gynaecological Oncology CentreGates Head; NottinghamUK

Prof Ahmed Ashour Consultant Gynaecological OncologyDirector of the Ovarian Cancer Cell LaboratoryMRC Weatherall Institute of Molecular MedicineUniversity of Oxford-UK.

Prof. Ahmed SekotoryMD FRCOG FACOGConsultant Gynaecological OncologistHon professor Alexandria and Zagazig UniversitiesPast Director of Gynaeoncology & Robotic SurgeryThe Christie NHS FTManchester UKGlobal Health Academy, UK

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

PHARMACY

AND

DRUG DISCOVERY

COURSE

Course Director and International Experts

Dr. Sahar RadyCourse Director

!

Prof. Ebtesam Ahmed Clinical Professor for the Department of Clinical Health ProfessionsSt. John's University New York,USA

Prof.Khaled AbouZidProf of Pharmaceutical Chemistry, Facultyof Pharmacy, Ain Shams University & University of Sadat City.

Topics*Clinical pharmacy :-Infectious diseases in oncology.-Overcoming barriers for cancer pain control.-Role of pharmacist in anticoagulation.-Immunotherapy symptoms management.*Clinical pharmacy workshop.

*Drug discovery :-Inducing MDM2 degradation as an anticancer strategy.-Imidazolo (2',1':2,3) thiazolo (4,5-d)pyridazin analogues as New Scaffold of DHFR Inhibitors: Synthesis, Antitumor Evaluation and Molecular Modeling study.-A new perspective for the modulation Estrogenic /Anti estrogenic properties of the antican-cer drug Tamoxifen.-Novel Non-Cyclooxygenase Inhibitory Derivatives of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) for Colorectal Cancer Chemoprevention.-Novel Chemotherapy as Potent Targeted Antiangiogenic Agents: Molecular Design, Synthesis and in vitro Biological Activity.

*Nutrition -Nutrition education for prophylaxis.-Natural medicine / myth or way of healthy living.-Nutrition & cancer beyond feeding.

*Precision Medicine -Gene therapy &cancer cells drug targeting: killing two birds with stone.-Pharmacogenetics of drugs withdrawn from the market.

* Biosimilars

Topics

RADIOLOGY COURSE

Breast Imaging from the Clinician’s View-point- The Role of Breast Imaging Radiologist in the Multidisciplinary Team- What do clinicians need to know about breast mass lesions? (size, site , number, skin attach, nipple infilt, pectoral muscle)- Ultrasound tumor lymph Node staging and management - Diagnostic Strategy of axillary lymphnodes in breast cancer patients. (pathological or no, biopsy or no, matted, supra and infraclavnodes)- Diagnostic work up of symptomatic patients.- Contrast Mammography and Dynamic MRI: which is right for who?

Pearls and Pitfalls in Breast Imaging- Skills to minimize the call-back rate for normal/benign findings at mammographic screening.- Sono-mammography morphology descriptors of benign and malignant breast lesions.- The missed breast carcinoma: why and how to avoid?- Diagnostic pitfalls in breast ultrasound.- Strategies to reduce false positives in screening mammography- Imaging the post surgical breast: sound and mal practice.- Benign cancer mimics.- Implementing DBT in Your Practice- Molecular Breast Imaging: where does it fit in?- Artificial Intelligence: What does it mean for us?- Breast Cancer in Young; a diagnostic challenge

Pelvic Imaging - Non-neoplastic disorders of the ovary and adnexae- MRI in Endometriosis- Ovarian Benign/Borderline/Malignant- Fibroid or leiomyosarcoma?- Multimodality imaging in Advanced Ovarian Cancer.- Imaging of the normal an abnormal endometrium.- Role of diffusion weighted imaging in uterine and cervical carcinomas.- How Does Imaging Direct Management in Patients with Cervical Cancer?- Pitfalls of diffusion-weighted imaging of gynecologic malignancies.- Pelvic Applications of Diffusion Magnetic Resonance Images.

Course Director and International Experts

Prof. Rasha Kamal Prof. Ahmed Emad Prof. Merit Al-MadawiConsultant Radiology ,Toronto

Prof. Ramona WoitekProfessor of radiodiagnosis , Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge , UK

Prof. Jessica Leung Professor of Diagnostic RadiologySection Chief of Breast Imaging,MD Anderson Cancer Center,Tx,USA

Topics

Prof. Gilda CardenosaM.D., Director of Breast Imaging at VCU Health,Massey , Cancer Center

Course Director & International Experts

Prof. Nelly SalemAssistant Professor of Radiology at Stanford University in Palo Alto, California.USA

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

th

&ImmunooncologyInternational Cancer Conference

Breast - Gynecological

In Collaboration with

SURGICALCOURSE

Course Directors and International Experts

Prof. Omar Z. Youssef Prof. Mohamed Shinawi

Prof. Mehra GolshanProfessor, Department of Surgery,Harvard Medical School Distinguished Chair,Surgical Oncology, Brigham & Women's HospitalDirector, Breast Surgical Services DFBWCC, Brigham And Women's Hospital, USA

Prof. Wu JiongVice President Chinese Anticancer Association Specialty Branch of Breast Cancer surgeryChina

- Global breast surgery updates- Innovations in surgical management of the axilla- Avoiding complications in breast surgery- Innovations in breast cancer therapy

Topics

Prof. Armando E. GiulianoLinda and Jim Lippman Chair in Surgical OncologyExecutive Vice Chair, Surgical Oncology in the Department of SurgeryCo-Director, Saul and Joyce Brandman Breast Center -A Project of Women's GuildAssociate Director, Surgical Oncology in the Samuel Oschin Comprehensive Cancer Institute, USA

Prof. Charles M. BalchPresident, Cancer Expert Now InternationalProfessor of SurgeryDepartment of Surgical OncologyUT MD Anderson Cancer Center,Houston Texas, USA

Prof. Benjamin O. AndersonChair and Director, Breast Health Global Initiative (BHGI)Full Member, Fred Hutchinson Cancer Research CenterProfessor of Surgery and Global Health Medicine, University of WashingtonSeattle, Washington USA

Prof. Ning Liao M.D, Ph.DChair and Director, Department of BreastCancer, Guangdong Cancer Center, GuangdongGeneral Hospital, and Guangdong Academy of Medical Sciences China

Prof. Ruslan Malikovich Paltuev CEO of RAOM(Russian Association of OncologyMammalogy)Russia

Prof. Bahadir GulluogluMarmara University School of MedicineDepartment of surgeryTurkey

Prof. Cheng-Har YipConnsultant Brest Surgical Past President BSIBreast Cancer Subang Jaya Medical Centre/Parkcity Medical CENTREClinical Professor Dept of Surgery, University Tanku Abdul RahmanEmirates Professor of Surgery, University Malaya Kuala LumpurMalaysia

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

TopicsBreast Radiotherapy:• Between high-tech and biology: how to exploit new delivery techniques to avoid toxicity• New Trends in Radiation Therapy for Breast Cancer. • Challenging cases in the radiotherapy of breast cancer• The optimal sequence in the treatment of breast cancer: is there a role for preoperative radiotherapy ? • CyberKnife in breast cancer.• Regional nodal irradiation: who might benefit most?Gyanecological Radiotherapy ;• Volumetric brachytherapy for Gynaecological malignancies • Do we need adjuvant vaginal vault brachytherapy for endometrial cancer? Yes or No • Stereotactic body radiotherapy in gynecological malignances.• The potential role of particle therapy in gynaecological cancers. • Radiotherapy prespective in locally advanced cancer cervixGyanecological Brachtherapy ESTRO-Falcon Radiotherapy Hands-On Workshop • Target volume delineation for Gynaecological tumors• Plan optimization and acceptance• Two practical cases Lung ESTRO-Falcon Radiotherapy Hands -On Workshop

RADIOTHERAPY COURSE

Course Director and International Experts

Prof. Khaled Abdelkarim Prof. Mohamed Abou El Fotouh

Prof. Roberto OrecchiaProfessor of radiation oncologyUniversity of Milan Italy

Prof. Maia DzhugashviliProfessor of Radiation OncologyMadrid Oncology Institute,Spain

Prof. Mohamed Elshaikh Senior Staff PhysicianHenry Ford HospitalProfessor of Radiation Oncology.Wayne State UniversityUSA

Prof. Philip M.P. PoortmansHead of Department of Radiation OncologyMarie Curie Professor Paris Science & Lettres – Institut CurieECCO PresidentFormer ESTRO President, France

Target Audience

- validate their contouring practice during live workshops by compar-ing them with those from experts and other participants- learn the indications proposed by the experts that coordinate the workshops- discuss with other participants, experts and panelists- communicate and use the delineation guidelines in order to further integrate themselves into daily practice

ToOffer the opportunity for individual professionals

Lung Radiotherapy & Gynaecology BrachytherapyHands On Target Delineation ( H.O.T) Workshops

Registration Fees : 100 $ Limited Number of Participants

The delineation workshops are aimed at Junior Clinical or Radiation Oncologists wanting to improve their contouring skills or more senior specialists wanting to refresh and valida-

te their knowledge and skills in this �eld. The delineation on OAR is speci�cally recom-mended for Radiotherapists, Radiation Physicits and Dosimetrists too

20

PATHOLOGYCOURSE

Breast Pathology Topics:• Evaluation of Breast Core Biopsies: A pattern based approach.• Breast Pathology: Diagnosing from basics• Critical Practice gaps in Breast Pathology :A case -based discussion • How to approach special types of breast of breast carcinomas on core biopsy samples.• Radio-pathologic correlation of different breast lesions.• Neoadjuvant therapy for breast carcinomas: Challenges for pathologists and clinical implications.• PD-L1 expression in breast cancer and immunotherapy.

GYN pathology Topics:• An approach to endometrial biopsy interpretation.• The differential diagnosis of a “fibroid”.• An update on ovarian tumors.• Molecular classification of endometrial carcinomas.• Prognostic aspect of Uterine Carcinosarcoma.

Topics

Prof. Manal El Mahdy

Prof. Rania BakkarAssociate Professor of PathologyDepartment of PathologyCedars Sinai Medical CenterUSA

Course Director and International Experts

Prof. Frederique Penault-LlorcaProfessor of PathologyDepartment of pathology, center jean-perrinClermont-FerrandPresident of the unicancer immunooncology group, France

Prof. Sunati Sahoo pathologist in Dallas, Texas and is affiliated with UT Southwestern Medical CenterUSA

Prof. Anupma NayakAssistant Professor of Pathology andLaboratory Medicine at the Hospital of the University of PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine, India

Prof. Rouba AliDirector of Gyne oncology tissue programharber university hospitalUSA

Prof . Nafisa WilkinsonConsultant Gynaecological Pathologist, Lead Gynae Pathologist, University College London Hospitals NHS Foundation TrustLeeds, West Yorkshire, UK

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

Palliative Care Course

Course Director and International Expert

Prof. Samy AlSirafy

!

Prof. Ebtesam Ahmed Clinical Professor for the Department of Clinical Health ProfessionsSt. John's University New York,USA

Prof. Carlos CentenoProfessor of Palliative Medicine, Faculty of Medicine, University of NavarraDirector of the Palliative MedicineUnit of the University of Navarra ClinicPamplona, Spain

Prof. Eduardo GarraldaGeneral Manager of the ATLANTES PalliativeCare Global ObservatoryInstitute for Culture and Society (ICS),University of NavarraPamplona, Spain

Palliative Care Course

- Palliative care in Egypt: an overview- Undergraduate palliative medicine education- Indicators of palliative care development- Advocacy for palliative care: the White Book- The development of palliative care in the Eastern Mediterranean region- Palliative Care in Egypt: the way forward

Course Director and International Experts

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

NURSINGCOURSE

Prof. Wafaa Ouda

Course Director

- New trends in nursing management of pediatric oncology- The role of family in care and follow up of cancer in children- Psychosocial aspects in nursing the pediatric oncology patients and their care giver- Infection as critical condition in care of pediatric cancer patients- Improve safety and quality of care of pediatric oncology patients- Nursing management of pediatric patients undergoing chemo and radiotherapy- Efficacy of orthopod venoms against cancer - Biodegradable nano polymer drug carriers for cancer therapy- Attitude , stress ors and coping pattens of family care givers towards cancer in children- The value of health education for pediatric oncology patients and their families - Pain management in cancer patients : the role of pediatric nurse- Nursing management of common cancer related complications and it is therapy

Nursing Aspects in Managing Cancer Breast

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

PREVENTIONSESSION

BREAST - GYNECOLOGICALINTERNATIONAL CANCER SOCIETY

Breast Cancer EpidemiologyBreast Cancer Screening:CBE versus Mammography

Breast Cancer Screening in High Risk PatientsNon Pharmco Prevention in Breast Cancer

Pharmco Prevention in Breast CancerCervix Cancer Screening HPV & Cervix Cancer

Cervix Cancer Vaccine and Prevention

BGICS-WHO-UICC -ESGO clinical practices Voting

Recommendations

BGICS-WHO-UICC -ESGO clinical practices Voting Recommendations

Slots are limited

book your place now

certified by

Nature research

Do not miss your opportunity to increase your research output, quality and impact with the world’s largest

research academy.

Prof. Mohamed Shinawi

Dr.Khaled Abdel Aziz

Coordinators

Prof. Hesham El Ghazaly

Faculty of Medicine Ain Shams Research InstituteBREAST - GYNECOLOGICAL

INTERNATIONAL CANCER SOCIETY

Faculty of Medicine Ain Shams Research Institute

Prof. Maimuna Mendy Group HeadLaboratory Services and Bio BankWHOFrance

Dr. Amany MaherDr. Sarah Hassan

Course Director

Prof. Hesham El Ghazaly

BGICS-MASRI Scientific Research Course : Updates

Topics

Prof. Elodie Caboux Assistant-Biobank Process Management, International Agency of Researchon Cancer (IARC), France

• MASRI MOLECULAR NETWORK : MASRI &USA , MASRI &CHINA , MASRI & ZEWAIL ,MASRI & OTHERS• EPIGENETIC MECHANISMS ACROSS SCALES: FROM MOLECULES TO ENVIRONMENT AND EVOLUTION• TRANSPOSABLE ELEMENTS AND EPIGENOME EVOLUTION• Programming Future Generations• Epigenetic mechanisms governing cell differentiation and cancer processes .• Integrative Single-Cell Chromatin and Transcriptome Profiling Uncovers Cell-Type Specific Regulatory Interactions .• Targeting Cancer Epigenome: strategies for prevention and treatment .• Molecular Biology and Medicine: A Primer for the Clinician .• Next-Generation Sequencing (NGS): Stimulating the Next Generation of Cancer Diagnostics and Treatment• Tumor Microenvironment Immune Diversity Revealed by Single-Cell Sequencing• Cancer as a Tissue Anomaly: Classifying Tumor Transcriptomes Based Only on Healthy Data• Oncogenomics: prospects for the future.• DNA Nanotechnology for Cancer Diagnosis and Therapy• Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection• High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number

Two Days Workshop :11th-12th January 2020NGS Data Analysis Workshop :Practical Analysis Variant Calling ,Chip-SequencingHands-On Workshop on whole Genome Next Generation Sequencing.

Course Coordinator

The abstract deadline is 1 December, 2019. Oral Presentations: Selection of abstracts, chosen by the Scientific Committee, will be presented as an oral presentations.Complete information (including presentation details, poster dimensions, etc.) will be provided after acceptance notification. Poster Presentations: All accepted abstracts will be displayed as posters throughout the meeting.Complete information (including poster dimensions) will be provided after acceptance notification.

All Accepted Abstract will be Published in Tumori Journal in separate supplement impact factor 1.234ABSTRACT SUBMISSION GUIDELINES please check web site www.bgicc.net

Include the following contact information for the presenting author: • First Name • Email • Last Name (Surname) • Fax• Degree(s) • Phone• Specialty or Department • Country• Institution/Affiliation • ZIP/Postal Code• Address • City

You will receive an email confirming receipt of your abstract. If you do not receive confirma-tion, please contact bgicc2010@gmail.com The Program Committee members will review your abstract, and you will be notified of their decision by December 12, 2019.

Presenting author should register to the conference maximum by 15th of December to ensure publiction.If you have any questions about the above guidelines, please contactProf. Hesham Elghazaly Tel : +2 01001300236E-mail :bgicc2010@gmail.com LA

ST

CA

LL F

OR

AB

STR

AC

TS

EARLY REGISTRATION(Before 30th of Nov. 2019)

LATE/ON-SITE REGISTRATION(After 30th of Nov. 2019)

NB: BGICS members will have 50% discount on registration fees.

Conference :400US $Workshops: 150 US $

Conference :700 US $Workshops: 300 US $

CONFERENCE VENUE: Hilton Heliopolis Hotel, Cairo, Egypt.Hilton Heliopolis Hotel & Resorts is the largest luxury hotel company, with a distinctive collection and a worldwidereputation for excellence. Their diverse portfolio includes historic icons, elegant resorts and modern city center properties.

GALLERY: Multinational & National Companies will exhibit their Equipments & Pharmaceutical products.

ACCOMMODATION

Accommodation in Hilton Heliopolis Hotel, per night: Single Room: 310 US $ Double Room: 340 US $

Accommodation in Radisson Blu Hotel per night: Single Room: 180 US $ Double Room: 210 US $

For ACCOMMODATION please contact us at : E-mail: araborganizers@hotmail.com With confirmation on E-mail: bgicc2010@gmail.com

OFFICIAL ORGANIZER:ARAB ORGANIZERS FOR CONFERENCE MANAGEMENTAddress : 14 Mohamed Mandour Rabaa El Adaweya St.,-Nasr CityTel.: 0222603653Mobile : +20 100 222 3158 +20 1068663434 +20 1068666085E-mail address : araborganizers@hotmail.com Website: www.araborganizers.org

FOR SCIENTIFIC INFORMATIONProf. Hesham El GhazalySecretary General of the BGICCTel : +2 01001300236bgicc2010@gmail.com